CLN5 anticorps
-
- Antigène Voir toutes CLN5 Anticorps
- CLN5 (Ceroid-Lipofuscinosis, Neuronal 5 (CLN5))
-
Reactivité
- Humain, Souris, Rat
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp CLN5 est non-conjugé
-
Application
- Western Blotting (WB), Immunohistochemistry (IHC)
- Purification
- Affinity purification
- Immunogène
- Recombinant fusion protein of human CLN5 (NP_006484.1).
- Isotype
- IgG
- Top Product
- Discover our top product CLN5 Anticorps primaire
-
-
- Indications d'application
- WB 1:500-1:2000 IHC 1:50-1:200
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- 1 mg/mL
- Buffer
- PBS with 0.02 % sodium azide, 50 % glycerol, pH 7.3
- Agent conservateur
- Sodium azide
- Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Stock
- -20 °C
- Stockage commentaire
- Store at -20°C. Avoid freeze / thaw cycles.
-
- Antigène
- CLN5 (Ceroid-Lipofuscinosis, Neuronal 5 (CLN5))
- Autre désignation
- CLN5 (CLN5 Produits)
- Synonymes
- anticorps NCL, anticorps A730075N08Rik, anticorps CLN5, intracellular trafficking protein, anticorps ceroid-lipofuscinosis, neuronal 5, anticorps CLN5, anticorps Cln5
- Sujet
- This gene is one of eight which have been associated with neuronal ceroid lipofuscinoses (NCL). Also referred to as Batten disease, NCL comprises a class of autosomal recessive, neurodegenerative disorders affecting children. The genes responsible likely encode proteins involved in the degradation of post-translationally modified proteins in lysosomes. The primary defect in NCL disorders is thought to be associated with lysosomal storage function.
- Poids moléculaire
-
Observed_MW: 50kDa
Calculated_MW: 41kDa
- ID gène
- 1203
- UniProt
- O75503
-